Currently, a great number of western companies declare the winding-up or suspension of their business activity in Russia. For many counterparties, which render services, perform works, or supply materials and goods to these companies (clients or a buyers), their winding-up inevitably leads to permanent or temporary ceasing of operations in the territory of the Russian Federation and, as a consequence, minimizing the associated costs of the Russian legal entity – at least for the next several months.

On 8 March 2022, Federal Law No. 46 “On Amending Certain Legislative Acts of the Russian Federation” entered into full force and effect, suggesting considerable changes in regulations and intellectual property in the pharmaceutical sphere.

As of 6 March 2022, several economic restrictions were imposed on the aviation sector.

On March 04, 2022, the Council of Federation has approved and sent to the President the Federal Law “On Amending Certain Legislative Regulations of the Russian Federation” (the “Law”). This Law provides for a number of changes in the regulation of procurement and circulation of medical products (“MP”) and medical devices (“MD”), corporate and financial relations, and even social matters.

As of 3 March 2022, a number of economic restrictions were imposed on the banking sector.

The Russian Government brought a draft law “On amendments to the Part IV o the Russian Civil Code” to the State Duma. 

Amendments to the Federal Law “On fundamental healthcare principles in the Russian Federation” will come into force on June 29, 2022, allowing doctors to prescribe off-label drugs to minors, i.e. for indications not specified in their instructions for use.

In the Resolution No. 45 of December 23, 2021, of the Russian Supreme Court Plenum (“Resolution”) the Russian Supreme Court clarified some issues of bringing to administrative liability under Articles 5.27, 5.27.1 of the Administrative Code of the Russian Federation (“Code”).